#3 - Health Care Select Sector SPDR Fund (NYSEARCA:XLV)
Another sector SPDR fund to consider is the Health Care Select Sector SPRD Fund (NYSEARCA: XLV). Health care is widely seen as an evergreen sector, as people need to get medical care regardless of economic conditions. However, there are areas – such as elective surgeries – that may do better when the consumer is less impacted by inflation. That’s reflected in the price of the XLV ETF, which is up 14% in 2024.
The fund has 50 holdings in a diverse range of industries, such as pharmaceuticals, healthcare providers, equipment and supplies, biotechnology, life sciences companies, and healthcare technology.
As of September 2024, almost 50% of the fund’s weighting is in biotechnology, with three of the fund’s top five holdings being Eli Lilly & Co. (NYSE: LLY), AbbVie Inc. (NYSE: ABBV), and Merck & Co. Inc. (NYSE: MRK).
Like the other SPDR funds, the XLF ETF has an ultra-low 0.09% expense ratio. It also pays a dividend with a 1.28% yield.
About Health Care Select Sector SPDR Fund
Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500).
Read More - Current Price
- $155.91
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 4 Buy Ratings, 17 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $166.10 (6.5% Upside)
